Short answer
Axogen, Inc. (AXGN) filed an 8-K current report with the SEC on April 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 financial results announced by Axogen on April 28, 2026.
Axogen, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results announced by Axogen on April 28, 2026
- Full financial details and management commentary contained in furnished Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- First-quarter 2026 financial results presentation posted April 28, 2026 under Regulation FD
- Investor materials available for analyst and shareholder discussions
- Updated corporate presentation posted, potentially signaling refreshed strategic messaging
- Exhibits 99.2 and 99.3 contain the substantive financial and corporate materials
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $61.5M, up 26.6% YoY, with gross margin improving to 75.2% from 71.9%
- Adjusted EBITDA $5.7M and adjusted net income $4.1M, while GAAP net loss reached $19.6M due largely to debt extinguishment costs
- Public offering raised $133.3M from 4.6M shares, funding repayment of the $69.7M Oberland facility and strengthening liquidity
- Cash, restricted cash, and investments increased to $103.6M from $45.5M at December 31, 2025
- Full-year guidance raised to at least 20% revenue growth, or $270M, with 74%-76% gross margin and positive free cash flow targeted
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Axogen, Inc. 8-K filings
Get the next AXGN 8-K as it lands
Follow AXGN for push alerts, or ask the research agent what this filing means.